Biogen Inc – Page 2

FDA Approves First Pill for Postpartum Depression

Because the pill works faster than other antidepressants and is taken for only two weeks, it may encourage more treatment of the debilitating condition.

By Pam Belluck

Biogen Inc Centers for Medicare and Medicaid Services Decisions and Verdicts Drugs (Pharmaceuticals) Eisai Co Ltd Food and Drug Administration Medicare Memory United States

FDA Makes Alzheimer’s Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.

By Pam Belluck

Biogen Inc Drugs (Pharmaceuticals) Food and Drug Administration Genetics and Heredity

F.D.A. Approves Drug for Rare Form of A.L.S.

The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.

By Rebecca Robbins

Biogen Inc Centers for Medicare and Medicaid Services Drugs (Pharmaceuticals) Eisai Co Ltd Food and Drug Administration Labeling and Labels (Product) Medicare New England Journal of Medicine Placebos United States

F.D.A. Approves New Treatment for Early Alzheimer’s

The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.

By Pam Belluck

mosaec